Skip to main content

2022 edition of  HealthTech Innovation Days: replay of “Translational microbiome medicine to treat serious oncology and infectious diseases”.

During one hour, industry leaders including our CEO Hervé Affagard and world-renowned specialists discussed how the gut #microbiota is becoming a cornerstone in treating serious diseases and cancer.

MaaT Pharma dans les médias MaaT Pharma in the News